DK1151300T3 - Assay til påvisning af en bindingspartner - Google Patents

Assay til påvisning af en bindingspartner

Info

Publication number
DK1151300T3
DK1151300T3 DK99966795.9T DK99966795T DK1151300T3 DK 1151300 T3 DK1151300 T3 DK 1151300T3 DK 99966795 T DK99966795 T DK 99966795T DK 1151300 T3 DK1151300 T3 DK 1151300T3
Authority
DK
Denmark
Prior art keywords
assay
detection
binding partner
leukemia
sample
Prior art date
Application number
DK99966795.9T
Other languages
English (en)
Inventor
Richard Ian Christopherson
Remedios Cristobal G Dos
Original Assignee
Medsaic Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPP7916A external-priority patent/AUPP791698A0/en
Priority claimed from AUPQ0425A external-priority patent/AUPQ042599A0/en
Application filed by Medsaic Pty Ltd filed Critical Medsaic Pty Ltd
Application granted granted Critical
Publication of DK1151300T3 publication Critical patent/DK1151300T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Basic Packing Technique (AREA)
  • Motorcycle And Bicycle Frame (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK99966795.9T 1998-12-23 1999-12-23 Assay til påvisning af en bindingspartner DK1151300T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPP7916A AUPP791698A0 (en) 1998-12-23 1998-12-23 An assay
AUPQ0425A AUPQ042599A0 (en) 1999-05-18 1999-05-18 An assay-ii
PCT/AU1999/001156 WO2000039580A1 (en) 1998-12-23 1999-12-23 An assay to detect a binding partner

Publications (1)

Publication Number Publication Date
DK1151300T3 true DK1151300T3 (da) 2010-07-12

Family

ID=25645962

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99966795.9T DK1151300T3 (da) 1998-12-23 1999-12-23 Assay til påvisning af en bindingspartner

Country Status (14)

Country Link
US (1) US7560226B2 (da)
EP (1) EP1151300B1 (da)
JP (1) JP4763135B2 (da)
KR (1) KR100795757B1 (da)
CN (1) CN1231761C (da)
AT (1) ATE466280T1 (da)
BR (1) BR9916449A (da)
CA (1) CA2356286C (da)
DE (1) DE69942314D1 (da)
DK (1) DK1151300T3 (da)
ES (1) ES2344180T3 (da)
NZ (1) NZ525421A (da)
PT (1) PT1151300E (da)
WO (1) WO2000039580A1 (da)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2319828A1 (en) * 1998-01-29 1999-08-05 Miller, Samuel High density arrays for proteome analysis and methods and compositions therefor
AUPR005600A0 (en) * 2000-09-12 2000-10-05 University Of Sydney, The Diagnostic assay
IL156446A0 (en) 2000-12-14 2004-01-04 Paul Stroobant Differential phage capture proteomics
EP1248108B1 (en) * 2001-03-29 2011-08-31 Canon Kabushiki Kaisha method of cellular screening and substrates suitable for it
EP1386155A4 (en) * 2001-04-10 2006-05-10 Univ Leland Stanford Junior THERAPEUTIC AND DIAGNOSTIC USE OF ANTIBODY SPECIFICITY PROFILES
WO2003058193A2 (en) * 2001-07-02 2003-07-17 The Board Of Trustees Of The Leland Stanford Junior University Microarrays for cell phenotyping and manipulation
ATE443259T1 (de) 2001-09-20 2009-10-15 Univ Texas Bestimmung der zirkulierenden therapeutischen antikörper, antigene sowie antigen-antikörper- komplexe mit elisa-tests
AU2003219275B2 (en) * 2002-03-07 2008-01-24 Cambridge Enterprise Ltd SCD fingerprints
WO2004001377A2 (en) * 2002-06-20 2003-12-31 Paul Stroobant Improved methods for performing differential capture proteomics
DE10236101A1 (de) * 2002-08-05 2004-02-26 NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen Verfahren und Kit zur Durchführung funktioneller Tests an biologischen Zellen
CA2518677A1 (en) * 2003-03-03 2004-12-09 Nagaoka & Co., Ltd. Methods and apparatus for use in detection and quantitation of various cell types and use of optical bio-disc for performing same
WO2004087865A2 (en) * 2003-03-31 2004-10-14 The Regents Of The University Of California The preparation and application of ligand-biopolymer conjugates
EP1611443A1 (en) * 2003-04-04 2006-01-04 Biacore AB Method and kit for cell analyte assay
SE0301058D0 (sv) 2003-04-10 2003-04-10 Biacore Ab Method and kit for cell analyte assay
US8242254B2 (en) 2003-09-11 2012-08-14 Ibis Biosciences, Inc. Compositions for use in identification of bacteria
US20080138808A1 (en) * 2003-09-11 2008-06-12 Hall Thomas A Methods for identification of sepsis-causing bacteria
US8546082B2 (en) * 2003-09-11 2013-10-01 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US8097416B2 (en) 2003-09-11 2012-01-17 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US20050069958A1 (en) * 2003-09-26 2005-03-31 Mills Rhonda A. Method for simultaneous evaluation of a sample containing a cellular target and a soluble analyte
DE102004039628A1 (de) * 2004-08-10 2006-02-23 NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen Trägerplatte zur Durchführung funktioneller Tests an biologischen Zellen sowie Verfahren zur Beschichtung der Trägerplatte
JP2008545399A (ja) * 2005-05-18 2008-12-18 ワイス 白血病疾患遺伝子およびその使用
US20060275852A1 (en) * 2005-06-06 2006-12-07 Montagu Jean I Assays based on liquid flow over arrays
US20070042443A1 (en) * 2005-08-17 2007-02-22 Quest Diagnostics Investments Incorporated Hematopoietic cell phenotyping using free circulating cellular markers
EP1941276A1 (de) * 2005-10-29 2008-07-09 Bayer Technology Services GmbH Verfahren zur bestimmung eines oder mehrerer analyten in komplex zusammengesetzten proben biologischen ursprungs und dessen verwendung
US20070105165A1 (en) * 2005-11-04 2007-05-10 Charles Goolsby Composite profiles of cell antigens and target signal transduction proteins for analysis and clinical management of hematologic cancers
JP5102772B2 (ja) 2005-11-29 2012-12-19 ザ・ユニバーシティ・オブ・シドニー デミボディ：二量体化活性化治療剤
US20070192884A1 (en) * 2006-01-25 2007-08-16 Daniel Chelsky TAT-038 and methods of assessing and treating cancer
WO2007137187A2 (en) 2006-05-18 2007-11-29 Molecular Profiling Institute, Inc. System and method for determining individualized medical intervention for a disease state
US8768629B2 (en) * 2009-02-11 2014-07-01 Caris Mpi, Inc. Molecular profiling of tumors
US20110003710A1 (en) * 2008-02-28 2011-01-06 John Hopkins University Selectin ligands useful in the diagnosis and treatment of cancer
GB0818614D0 (en) * 2008-10-10 2008-11-19 Univ Dublin City Platelet Analysis
CN106153918A (zh) * 2008-10-14 2016-11-23 卡里斯Mpi公司 描绘肿瘤类型生物标志模式和特征集的基因靶和基因表达的蛋白靶
CA2743211A1 (en) 2008-11-12 2010-05-20 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Methods and systems of using exosomes for determining phenotypes
US9128101B2 (en) 2010-03-01 2015-09-08 Caris Life Sciences Switzerland Holdings Gmbh Biomarkers for theranostics
WO2011127219A1 (en) 2010-04-06 2011-10-13 Caris Life Sciences Luxembourg Holdings Circulating biomarkers for disease
WO2012048372A1 (en) * 2010-10-11 2012-04-19 Medsaic Pty Ltd Assay for disease detection
EP2743701B1 (en) 2011-08-12 2016-04-27 LSI Medience Corporation Method of diagnosing surgical site infections
CN103235124A (zh) * 2013-04-22 2013-08-07 复旦大学 一种基于硝酸纤维素膜的便捷癌细胞捕获芯片
JP6715766B2 (ja) * 2013-06-21 2020-07-01 ザ ジョンズ ホプキンス ユニバーシティ ヒト膜蛋白質の機能および相互作用をプロファイリングするためのビリオンディスプレイアレイ
CN107076764A (zh) * 2014-11-20 2017-08-18 通用电气医疗集团英国有限公司 检测稳定在固体载体材料上的痴呆和阿尔茨海默病相关生物标记
CN105005484B (zh) * 2015-08-12 2021-04-20 厦门雅基软件有限公司 一种跨平台游戏开发工具的事件分发方法
AU2018301222A1 (en) * 2017-07-08 2020-01-30 The General Hospital Corporation Screening platform to identify therapeutic drugs or agents for treatment of alzheimer's disease
CN119798359B (zh) * 2025-01-06 2026-04-21 兰州大学 一种基于巯基-烯烃光点击化学的环肽构建方法及其应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA822896B (en) * 1981-04-29 1982-12-29 Ciba Geigy New devices and kits for immunological analysis
US4591570A (en) * 1983-02-02 1986-05-27 Centocor, Inc. Matrix of antibody-coated spots for determination of antigens
US4797356A (en) 1985-12-02 1989-01-10 Konishiroku Photo Industries, Co., Ltd Monoclonal antibodies specific to glactosyltransferase isoenzyme II and their use in cancer immunoassays
US5426029A (en) * 1986-03-31 1995-06-20 T Cell Diagnostics, Inc. Therapeutic and diagnostic methods using leukocyte surface antigens
US5217869A (en) 1987-10-13 1993-06-08 Terrapin Technologies, Inc. Method to produce immunodiagnostic reagents
GB8810400D0 (en) * 1988-05-03 1988-06-08 Southern E Analysing polynucleotide sequences
US5059522A (en) * 1988-08-18 1991-10-22 Wayne Lawrence G Intrinsic enzyme dot blot immunoassay or indentification of microorganisms
US6040138A (en) * 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US5532135A (en) 1990-02-02 1996-07-02 Cancer Research Fund Of Contra Costa Solid-phase competitive assay utilizing a fusion protein
US5726064A (en) * 1990-11-22 1998-03-10 Applied Research Systems Ars Holding Nv Method of assay having calibration within the assay
US5234816A (en) * 1991-07-12 1993-08-10 Becton, Dickinson And Company Method for the classification and monitoring of leukemias
US5597735A (en) * 1992-05-11 1997-01-28 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Health And Welfare Glycolipids for serodiagnosis of tuberculosis and leprosy
EP0656947A1 (en) * 1992-08-21 1995-06-14 Schering Corporation Human interleukin-13
ES2051651B1 (es) * 1992-12-10 1995-01-01 Univ Salamanca Procedimiento para la cuantificacion simultanea, en una sola medicion, de los principales tipos de linfocitos humanos y sus subpoblaciones.
DE69426948T2 (de) * 1993-02-09 2001-10-11 Becton Dickinson And Co., Franklin Lakes Automatische Bestimmung der Zellinie schwerer Leukämien durch Flusszytometrie
WO1995005604A2 (en) * 1993-08-13 1995-02-23 Molecular Geriatrics Corporation Methods for the diagnosis of alzheimer's disease
US5692220A (en) * 1993-09-02 1997-11-25 Coulter Corporation Decision support system and method for diagnosis consultation in laboratory hematopathology
ATE274577T1 (de) * 1993-10-06 2004-09-15 Univ Florida Stammzellen-proliferations-faktor
US5861158A (en) * 1993-11-17 1999-01-19 The United States Of America As Represented By The Deptartment Of Health And Human Services Method and composition for transfer of active tumor-specific immunization from an immunized allogeneic bone marrow donor
JP3533541B2 (ja) * 1995-01-25 2004-05-31 旭メディカル株式会社 細胞選択フィルター
US5633161A (en) * 1995-03-29 1997-05-27 Millennium Pharmaceuticals, Inc. Murine gene fomy030 coding for tumor progression inhibitor
US6265150B1 (en) * 1995-06-07 2001-07-24 Becton Dickinson & Company Phage antibodies
US5968513A (en) 1996-06-24 1999-10-19 University Of Maryland Biotechnology Institute Method of promoting hematopoiesis using derivatives of human chorionic gonadotropin
WO1998008083A1 (en) * 1996-08-20 1998-02-26 Motorola Inc. Method and apparatus for detecting predetermined molecular structures in a sample
US6087102A (en) 1998-01-07 2000-07-11 Clontech Laboratories, Inc. Polymeric arrays and methods for their use in binding assays
CA2318175A1 (en) 1998-02-04 1999-08-12 Invitrogen Corporation Microarrays and uses therefor

Also Published As

Publication number Publication date
BR9916449A (pt) 2002-01-22
JP4763135B2 (ja) 2011-08-31
CN1231761C (zh) 2005-12-14
CA2356286A1 (en) 2000-07-06
DE69942314D1 (de) 2010-06-10
US7560226B2 (en) 2009-07-14
PT1151300E (pt) 2010-06-21
EP1151300A4 (en) 2002-07-31
EP1151300A1 (en) 2001-11-07
US20020019018A1 (en) 2002-02-14
JP2002533723A (ja) 2002-10-08
WO2000039580A1 (en) 2000-07-06
KR100795757B1 (ko) 2008-01-21
NZ525421A (en) 2004-10-29
ES2344180T3 (es) 2010-08-19
CA2356286C (en) 2010-12-21
CN1334922A (zh) 2002-02-06
ATE466280T1 (de) 2010-05-15
HK1041922A1 (en) 2002-07-26
KR20010093221A (ko) 2001-10-27
EP1151300B1 (en) 2010-04-28

Similar Documents

Publication Publication Date Title
EP1151300A4 (en) TEST FOR THE DETECTION OF A LINK PARTNER
TR200000565T2 (tr) Biyolojik örneklerdeki analiz bileşenlerinin hızlı analizi için yöntem
SE9502196L (sv) Immunanalys och testkit med två reagens som kan tvärbindas om de adsorberats till analyten
EP0797777A4 (en) Device for performing one or more competitive immunoassays
DE69423896D1 (de) Testvorrichtung mit gefangenem teilchen-reagens
TR200001765T2 (tr) Duyguları ayırt etmek için aletler ve yöntemler.
DE69624920D1 (de) Testreagentien und Testvorrichtungen
AU9066998A (en) Use of check surfaces for identifying disturbing samples in a detection procedure
DE60226641D1 (de) Antikörperkategorisierung auf der grundlage von bindungseigenschaften
ATE223575T1 (de) Einstufige immunochromatographische vorrichtung und verfahren zu ihrer verwendung
DE69521104D1 (de) Spezifische Bindungstests und Reagenzien dafür
ATE339687T1 (de) Immunologische verfahren, vorrichtungen und reagenzien
TR200001313T2 (tr) Protein etkileşimlerini ve fonksiyonel ilişkileri kaydeden tarama sistemleri
DE69928507D1 (de) Festphasenverfahren und testsatz zur antigen- und antikörperprüfung in der blutgruppen-serologie
ATE256501T1 (de) Testträger zur chemischen und/oder biochemischen analyse
NO20083610L (no) Cobalamin-maling
DE69732034D1 (de) Assay-verfahren
CA2274776A1 (en) Method for analyzing annexin v in urine and use thereof
ATE208040T1 (de) Immunoassay-reagenzien, testsätze und verfahren
DK1295126T3 (da) Immunoanalysesystemer til påvisning af hepatitis C-virusantigen
ES2107828T3 (es) Inmunoensayo.
DK72082A (da) Cytoreceptor-proeve
ATE312203T1 (de) Dynamische bestimmung von analyten durch arrays auf inneren oberflächen
DK0998974T3 (da) Fremgangsmåde til målrettet anbringelse af reagenser på immobiliseret biologisk materiale